Clinical remission by BMI in patients with severe eosinophilic asthma (SEA) over 1 year post benralizumab: real-world XALOC-2 programme

被引：0
|
作者：
Lommatzsch, Marek [1 ]
Rothe, Thomas [2 ]
Emmanuel, Benjamin [3 ]
Tran, Trung N. [3 ]
Menzies-Gow, Andrew [4 ]
Shavit, Anat [3 ]
Cohen, David [3 ]
Ho, Calvin N. [3 ]
Plate, Tanja [5 ]
Kayaniyil, Sheena [6 ]
Herreman, An [7 ]
Schuoler, Claudio [8 ]
Dupont, Lieven [9 ]
Penz, Erika [10 ]
机构：
[1] Univ Rostock, Rostock, Germany
[2] Cantonal Hosp GR Chur, Chur, Switzerland
[3] AstraZeneca, Gaithersburg, MD USA
[4] AstraZeneca, Cambridge, England
[5] AstraZeneca, Wedel, Germany
[6] AstraZeneca, Mississauga, ON, Canada
[7] AstraZeneca, Groot Bijgaarden, Belgium
[8] AstraZeneca, Baar, Switzerland
[9] Univ Hosp Leuven, Leuven, Belgium
[10] Univ Saskatchewan, Saskatoon, SK, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA3932
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Early response and remission with benralizumab in patients with severe asthma and chronic rhinosinusitis with nasal polyposis (CRSwNP) in the prospective real-world ImPROve Asthma study
    Korn, S.
    Watz, H.
    Emmanuel, B.
    Plate, T.
    Saathoff, M.
    Shavit, A.
    Grund, T.
    Lommatzsch, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [32] Effectiveness of mepolizumab in patients with severe eosinophilic asthma: results from real-world clinical practice in Finland
    Koistinen, Ville
    Kauppi, Paula
    Idanpaan-Heikkila, Juhana
    Veijalainen, Lauri
    Iso-Mustajarvi, Ilona
    Ylisaukko-Oja, Tero
    Mehtala, Juha
    Viinanen, Arja
    Kilpelainen, Maritta
    JOURNAL OF ASTHMA, 2022, 59 (12) : 2375 - 2385
  • [33] PATIENT-REPORTED OUTCOMES OF BENRALIZUMAB IN REAL-WORLD USE IN SEVERE EOSINOPHILIC ASTHMA PATIENTS: INTERIM RESULTS FROM THE IOUTRUN STUDY-
    Al-Lehebi, Riyad O.
    Al-Ahmad, Mona
    Abuzakouk, Mohamed
    Alzaabi, Ashraf
    Campusano, Angela Elizabeth Araujo
    Garcia, Natalia
    Ramaswamy, Logamurthy
    Maturu, Nagarjuna V.
    Conde-Camacho, Rafael
    Gallego, Manuel Conrado Pacheco
    Joshi, Sachin
    Farouk, Hisham
    CHEST, 2024, 166 (04) : 67A - 68A
  • [34] Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab:a post-hoc analysis of the 2-year RELIght study
    Papaioannou, Andriana
    Kallieri, Maria
    Zervas, Eleftherios
    Fouka, Evangelia
    Porpodis, Konstaninos
    Hadjimitrova, Marija
    Tzortzaki, Eleni
    Makris, Michael
    Ntakoula, Maria
    Lyberopoulos, Panagiotis
    Dimakou, Katerina
    Koukidou, Sofia
    Ampelioti, Sevasti
    Papaporfyriou, Anastasia
    Katsoulis, Konstantinos
    Kipourou, Maria
    Rovina, Nikoletta
    Antoniou, Katerina
    Vittorakis, Stylianos
    Bakakos, Petros
    Steiropoulos, Paschalis
    Markopoulou, Katerina
    Avarlis, Panteleimon
    Papanikolaou, lias
    Markatos, Miltiadis
    Gaki, Eleni
    Samitas, Konstantinos
    Glynos, Konstantinos
    Papiris, Spyros
    Papakosta, Despoina
    Tzanakis, Nikolaos
    Gaga, Mina
    Kostikas, Konstantinos
    Loukides, Stelios
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [35] A Real-World Study of Achievement Rate and Predictive Factors of Clinical and Deep Remission to Biologics in Patients with Severe Asthma
    Oishi, Keiji
    Hamada, Kazuki
    Murata, Yoriyuki
    Matsuda, Kazuki
    Ohata, Syuichiro
    Yamaji, Yoshikazu
    Asami-Noyama, Maki
    Edakuni, Nobutaka
    Kakugawa, Tomoyuki
    Hirano, Tsunahiko
    Matsunaga, Kazuto
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (08)
  • [36] Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)
    Martinez-Moragon, Eva
    Garcia-Moguel, Ismael
    Nuevo, Javier
    Resler, Gustavo
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [37] Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)
    Eva Martínez-Moragón
    Ismael García-Moguel
    Javier Nuevo
    Gustavo Resler
    BMC Pulmonary Medicine, 21
  • [38] Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study
    Garcia-Moguel, Ismael
    Rosado, Ana
    Gomez-Cardenosa, Aida
    Gandolfo-Cano, Mar
    Robledo Echarren, Teresa
    Moro Moro, Maria del Mar
    Reano Martos, Ma del Mar
    Pineda-Pineda, Rafael
    Valverde-Monge, Marcela
    Martin-Arriscado Arroba, Cristina
    Dominguez-Ortega, Javier
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 623 - 632
  • [39] Real-World Impact of Mepolizumab on the Oral Corticosteroid Freedom Component of Clinical Remission in Severe Eosinophilic Asthma: International, Prospective REALITI-A Study
    Chupp, Geoffrey
    Heaney, Liam
    Price, Rob
    Brusselle, Guy
    Gardiner, Frances
    Raimondi, Alejandro
    Chaudhuri, Rekha
    Howarth, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB20 - AB20
  • [40] Long-Term Real-World Outcomes of Mepolizumab and Benralizumab Among Biologic-Naive Patients With Severe Eosinophilic Asthma: Experience of 3 Years' Therapy
    Fyles, Fred
    Nuttall, Amy
    Joplin, Hannah
    Burhan, Hassan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (09): : 2715 - 2723
12345